Tips Round-Up (Premium)
Investors in Judges Scientific should hold on to a "decent" amount of their shares in the company, even if they may be tempted to take some profits now at 8,500. 0p, the Financial Mail on Sunday's Midas column said.
The Financial Mail on Sunday's Midas column recommended readers buy shares of Serabi Gold, telling them that production was recovering and that profits were set to soar.
The Sunday Times's Lucy Tobin told readers that shares of business recovery specialist, Begbies Traynor, are a 'buy' given the outlook for a rise in corporate insolvencies.
The Financial Mail on Sunday's Midas column tipped shares of Auction Technology Group to readers, saying they offered "clear, long-term potential".
The Financial Mail on Sunday's Midas column recommended shares of Impact Healthcare, as 'a long-term buy', touting the company's long-term growth prospects, dividend yield of over 5. 0% and management's attention to detail which they surmised was paying off.
The Sunday Times's Lucy Tobin tipped shares of neuroscience outfit Cambridge Cognition Holdings to readers.
The Financial Mail on Sunday's Midas column told readers to hold onto their shares of MP Evans, the producer of sustainable Indonesian palm oil.
The Financial Mail on Sunday's Midas column recommended shares of five companies to readers, pointing out that history proved that the best time to buy shares was often when everyone else was running scared.
The Financial Mail on Sunday's Midas column told readers to 'buy' shares of Defence outfit Chemring, arguing that the tide was turning for the sector as a whole due to heightened geopolitical tensions.
The Sunday Times's Sabah Meddings told readers to 'buy' shares of Made. com, predicting that the online furniture retailer would profit from easing supply snags and still high demand from millennials Europeans too.
The Sunday Times's Sabah Meddings told readers to buy shares of Mirriad, arguing that trends in advertising were going the company's way.
The Financial Mail on Sunday's Joanne Hart told readers of the Midas column that the investment case for shares of BP and Shell now "seems pretty clear" and argued that both were likely to continue "richly rewarding" their shareholders via dividend payouts over the next five years.
The Financial Mail on Sunday's Midas column recommended readers 'buy' shares in Mears Group, arguing that their price did not reflect "recent progress, prospects or the resilience through tough economic times".
The Sunday Times's Robert Watts thinks readers should be shares of Mitchells & Butlers.
The Financial Mail on Sunday's Midas column touted shares of Hargreaves Services to readers, telling them that the now transformed business was "robust" and "resilient".
The Sunday Times's Sabah Meddings recommended investors 'sell' their shares of Aston Martin following the sports car-maker's recent profit warning.
Revolution Bars is worth a punt, a small one, admittedly, the Sunday Times's Jim Armitage told readers, and even then it is a very high risk punt.
The Sunday Times's Sabah Meddings told investors to 'buy' shares of Hollywood Bowl, telling them looked recent sales growth looked "promising" - "barring significant further Covid restrictions".
The Financial Mail on Sunday's Midas column told readers to 'buy' shares of Virgin Wines telling them that fears that the company would be negatively impacted by the snarl-up in global supply chains were overdone.
The Financial Mail on Sunday's Midas column called attention to Rainbow Rare Earths's shares, pointing out that it was shaping up to become one of the largest producers outside of China of two key rare earth metals, praseodymium and neodymium.